Arbesda RespiClick (fluticasone propionate/salmeterol xinafoate)

pCPA File Number: 21073
Negotiation Status:
Concluded without agreement
Indication(s):
Asthma
Sponsor/Manufacturer:
Teva Canada Limited
CDA-AMC Project Number:
SR0540-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: